What’s changing in how we treat transfusion dependence in anemia?

A roundtable discussion on anemia management in myelodysplastic syndromes (MDS), featuring Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center; Amy DeZern, MD, MHS, of Johns Hopkins Medicine; Uma Borate, MBBS, of Ohio State University; and Tiffany Tanaka, MD, of the University of California San Diego, examines early intervention strategies for anemia. Key topics include intervening before transfusion dependency, comparing transfusion-dependent and independent states, and the role of clonal cytopenia of undetermined significance (CCUS) as a precursor to MDS. The panel discusses treating anemia early with agents such as luspatercept or ESAs, to improve outcomes and prevent complications.

Watch more of the MDS roundtable discussion.